News & Events

Category: News

Roche will share patient-level clinical study data on Vivli

“We are thrilled to welcome Roche as a member of Vivli and to be able to list their studies on the platform,” said Rebecca Li, Vivli Executive Director.Roche logo

Roche is a global health care leader in the areas of oncology, immunology, infectious diseases and neuroscience. Through innovation in diagnostics and targeted treatments, Roche aims to improve the health and quality of life of patients around the world.

“Roche is delighted to be joining Vivli and to work in partnership with them to share our data through the Vivli platform,” said Jeff Helterbrand, Global Biometrics Head at Roche. “Especially during this critical time of public health challenge, we welcome the opportunity to work with a trusted partner.”

For more information about how Roche shares data on Vivli, please visit their member page. For additional information about Membership in Vivli, learn more here.

Lundbeck joins Vivli as a member

“We are pleased to announce Lundbeck has signed on as a member of Vivli,” said Rebecca Li, Vivli Executive Director. “We look forward to collaborating and providing their data to researchers in disease areas within psychiatry and neurology.”

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases. Lundbeck is engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world, with products targeted in psychiatry and neurology.

“Participating in a global data sharing platform such as Vivli is just one example of how we cooperate to ensure the best possible foundation for innovation and the development of new treatment solutions,” said Lars-Peder Haahr, Lead Project Director at Lundbeck.

For more information on how Lundbeck shares its data on Vivli, please visit their member page. For additional information on Vivli membership, learn more here.

Ida Sim to present at NIH webinar for COVID-19 Data Sharing

Vivli’s co-founder Ida Sim to speak at a webinar hosted by the National Library of Medicine (NLM) at the National Institutes of Health (NIH) for researchers to learn how to share, discover, and cite COVID-19 data and code in generalist repositories. Dr. Sim will speak to Vivli’s involvement in supporting discoverability and reusability of COVID-19 data on Friday, April 24th at 2:10 pm ET.

View Dr. Sim’s slides from the presentation.

Privacy Analytics partners with Vivli to offer anonymization of COVID-19 vaccine and pivotal trials

Privacy Analytics has partnered with Vivli in a consortium to accelerate the COVID-19 response through sharing of participant data from COVID-19 clinical trials via Vivli’s COVID-19 portal.

“Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have the collective will, the personal urgency and the technical ability to make a meaningful difference in the fight against COVID-19,” said Sarah Lyons, General Manager, Privacy Analytics. “We are committed to working with Vivli and doing our part to accelerate treatment for COVID-19. I am encouraged and inspired by the dedication and the devotion of our team, and by the speed with which the global healthcare community has rallied in this time of crisis.”

As jointly announced at our April 2 webinar, Privacy Analytics will waive fees to anonymize data from qualifying COVID-19 vaccine and pivotal drug trials. Vivli has also waived all fees to share, archive and access COVID-19 trials.

“We are appreciative of our long-term partnership with Privacy Analytics,” said Rebecca Li, Vivli Executive Director. “Making anonymization as easy as possible for those sharing COVID-19 clinical trials is a vital step forward so that these data can be shared more widely.”

Share your COVID-19-related Trials on the Vivli Portal

d-wise offers anonymization services to studies available on Vivli COVID-19 portal 

Breaking News— d-wise and Vivli are partnering to accelerate COVID-19 data sharing.  d-wise will waive fees to anonymize COVID-19 studies made available through the Vivli platform. Vivli launched its COVID-19 portal last week and announced it will waive fees to share, archive and access all of its clinical trials related to COVID-19.

“We are deeply grateful by the offers of support we have received to lower the barriers to those conducting COVID-19 clinical trials,” said Rebecca Li, Vivli Executive Director. “Making anonymization as easy as possible for those sharing COVID-19 clinical trials is a vital step forward so that these data can be shared more widely. We are pleased to be able to provide an end-to-end offering for COVID-19 data sharing.”

“Sharing data powers medical innovation. The time is now – we encourage those conducting clinical research to contribute and share data as part of the global response,” said Stephen Baker, Director of Strategic Accounts at d-wise. “d-wise is proud to play its part to accelerate the sharing ecosystem in the fight against COVID-19.”

Vivli is working with d-wise, along with other stakeholders, to share the data from COVID-19 trials.

About d-wise:

 d-wise is committed to helping pharmaceutical, biotech, contract research organizations, and medical device companies navigate technology change in pursuit of human health and wellbeing. With deep domain experience in biometrics, software engineering, statistical programming, standards, and change management, d-wise products and services power innovation to accelerate clinical trial data analysis and data sharing.

For questions and inquiries, please contact d-wise at info@d-wise.com or visit www.d-wise.com/transparency.

If you have other ways you can contribute to the COVID-19 effort, please let us know.

The current pandemic represents an opportunity for scientists and partners to work together towards a global response. On March 20, 2020  for sharing of clinical trials. All fees will be waived for sharing and access. Find out more about the process.

Vivli announced the launch of the COVID-19 portal as part of our desire to do our part in response to the global pandemic. We believe this will help us work toward our ultimate vision to advance human health through clinical research data sharing and to respect and honor the contributions of clinical research participants. As we all confront this challenging situation, the time for sharing data and ensuring that we are all doing what we can as a scientific community to advance human health has never been more pressing.

If you or your organization has research data from a COVID-19 related trial to share or wish to connect with Vivli on how your organization can help, please get in touch with us in filling out the form below and we will respond shortly.


    website is protected by reCAPTCHA v3

    Regeneron joins Vivli as a member

    Regeneron joins Vivli, reinforcing their commitment to data transparency

    “We are pleased to welcome Regeneron as a member of Vivli,” said Rebecca Li, Vivli Executive Director. “Regeneron is acting on its commitment to drive forward scientific discovery and advance human health by sharing individual patient-level clinical data from certain completed trials with approved researchers.”Regeneron logo

    Regeneron is a leading biotechnology company that delivers life-transforming medicines for people with serious diseases.

    For more information about how Regeneron shares clinical trial data on Vivli, please visit their member page. For additional information about Membership in Vivli, learn more here.

    Vivli is leading global non-profit data sharing platform that serves the international community and supports biotechnology companies like Regeneron to further their commitment in data transparency.

    Vivli to launch a portal for sharing data from COVID-19 trials

    Access to data from completed coronavirus trials would be made available to all qualified researchers

    Cambridge, MA–In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Data, has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data. All member and user fees would be waived for sharing and access.

    “Today, we are announcing this initiative as it is so important for the entire data sharing community to come together and do everything we can to share the data from these completed clinical trials,” said Rebecca Li, Vivli Executive Director. “Sharing data transparently and openly is the best way to honor the decisions made by participants in these trials and bring us closer to safe and effective treatments and vaccines.”

    Vivli co-founder, UCSF professor and lead author of a Science article published today that advocates for more open data sharing by the NIH echoed these concerns.

    “Vivli has been at the forefront of data sharing and I am delighted to see us do all that we can to advance the knowledge around the COVID-19 pandemic,” Sim said. “Vivli was created to make data sharing practical and easy to do. COVID-19 trials should be made open to all researchers so that no stone is left unturned in reviewing and analyzing the data.”

    The new article, published in the Policy Forum section of Science by Vivli and key data transparency leaders advocates for additional changes and enhancements to strengthen the current draft NIH Data Sharing Policy. In the piece the authors recommend, “Specific, practical, and implementable NIH policies can help transform academic culture and practice toward routine data sharing.”

    Authors of the article include Ida Sim, Michael Stebbins, Barbara E. Bierer, Atul J. Butte, Jeffrey Drazen, Victor Dzau, Adrian F. Hernandez, Harlan M. Krumholz, Bernard Lo, Bernard Munos, Eric Perakslis, Frank Rockhold, Joseph S. Ross, Sharon F. Terry, Keith R. Yamamoto, Deborah A. Zarin and Rebecca Li.

    About Vivli

    Vivli is a non-profit organization working to advance human health through the insights and discoveries gained by sharing and analyzing data. It is home to an independent global data-sharing and analytics platform which serves all elements of the international research community. The platform includes a data repository, in-depth search engine and cloud-based analytics, and harmonizes governance, policy and processes to make sharing data easier. Vivli acts as a neutral broker between data contributor and data user and the wider data sharing community. For more information, visit www.vivli.org and follow us on Twitter @VivliCenter.

    Vivli makes additional software and R packages available in its research environment

    More than 300 R packages and 250 Python packages are available

    We are delighted to announce the latest release of the Vivli platform included updates to the software and R packages available in the research environment.

    We have updated the complete list of Software and R packages available in Vivli’s research environment to reflect these changes. Any researcher environments provisioned after March 14, 2020, will have this software included as standard and existing research environments can have these updated software and packages included upon request. Reach out to support@vivli.org for more information.

    Vivli’s response to Coronavirus COVID-19

    We hope you are well in this moment of uncertainty due to COVID-19.

    We are reaching out at this time to let you know the steps we are taking to safeguard the well-being of both our employees and users.

    • Staying in contact via remote technology whenever possible. We are a dispersed team primarily
    concentrated in the Boston-area and are well-versed in the use of these remote technologies.
    • Minimizing all non-essential business travel.
    • Working closely with our vendors to minimize the potential impact of any user disruptions on the
    Vivli platform.
    • We will keep you updated as needed as the situation evolves.

    In the meantime, please continue to direct all inquiries to support@vivli.org

    Webinar: Data Sharing and Data Anonymization–the Vivli-Privacy Analytics Partnership

    Join Vivli and Privacy Analytics for a discussion of how both organizations help data contributors to share their data securely and protect patient’s privacy. The webinar will include discussions about the different approaches to anonymization and the value of a risk-based, quantitative anonymization approach. Learn more about how together we are building research communities to advance scientific research and creating trustworthiness through transparency. The webinar will be held on April 2nd at 10 am ET.

    Our key topics include:
    • Overview of the regulatory landscape
    • Importance of data-sharing and secondary-use of data
    • The fundamentals of anonymization

    RECORDING 

    Presenters:
    Rebecca Li, Vivli
    Niamh McGuinness, Privacy Analytics